Factors Affecting Adverse Effects after Kidney Transplantation

Show simple item record

dc.contributor.author Benlier, Necla
dc.contributor.author Güzel, Hatice
dc.contributor.author Korkmaz, Medet
dc.contributor.author Yüzbaşıoğlu, Mehmet Fatih
dc.date.accessioned 2021-12-07T13:12:46Z
dc.date.available 2021-12-07T13:12:46Z
dc.date.issued 2018
dc.identifier.issn 2564-7784
dc.identifier.issn 2564-7040
dc.identifier.uri http://openaccess.sanko.edu.tr/xmlui/handle/20.500.12527/600
dc.description.abstract Objective: The incidence of developing adverse effects in recipients after kidney transplantation (Tx) was analyzed.Methods: A total of 206 patients (mean age was 41.40±11.88 years, 92.7% were between 46 and 59 years old, and 66.0% were men) whounderwent Tx between 2011 and 2016 were evaluated retrospectively. Information regarding the sociodemographic characteristics ofthe patients was collected using the “Sociodemographic Characteristics Data Collection Form,” which was created by the researcher.Results: Various adverse effects were detected in 206 patients who participated in our study. The incidence of adverse effects wassignificantly higher in patients who had hypertension and chronic glomerulonephritis who underwent dialysis treatment during0–12 months before Tx and who received a kidney transplant from a living donor (p=0.001). The incidence of adverse effects relatedto the immunosuppressive drugs used after transplantation was significantly higher in patients receiving mycophenolate mofetil(MMF)+steroid+tacrolimus and MMF+steroid+cyclosporine, and weight gain was higher in patients receiving the same group of drugs(p=0.001). There were no significant differences in terms of adverse effects that occurred in other drug combinations.Conclusion: We found that many factors (e.g., immunosuppressive drugs) in Tx patients may be associated with the incidence of adverseeffects. en_US
dc.language.iso English en_US
dc.publisher AVES Yayıncılık en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.title Factors Affecting Adverse Effects after Kidney Transplantation en_US
dc.type Article en_US
dc.relation.journal European Journal of Therapeutics en_US
dc.identifier.issue 4 en_US
dc.identifier.startpage 198 en_US
dc.identifier.endpage 203 en_US
dc.identifier.volume 24 en_US
dc.identifier.doi https://doi.org/10.5152/EurJTher.2017.281 en_US
dc.contributor.sankoauthor Necla Benlier en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Gazimuhtar Paşa Bulvarı
No:36
27090
Şehitkamil / GAZİANTEP